Huadong Medicine Co Ltd (000963) — Capital Reinvestment Ratio
Latest as of September 2025:
1.90x
Huadong Medicine Co Ltd (000963) has a Capital Reinvestment Ratio of 1.90x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥155.98 Million) in capital expenditures (CN¥297.09 Million). See 000963 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.90x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥155.98 Million
CNY
Capital Expenditures
CN¥297.09 Million
CNY
Data as of
Sep 2025
Most recent filing
Huadong Medicine Co Ltd Capital Reinvestment Ratio (1998–2024)
This chart tracks Huadong Medicine Co Ltd's Capital Reinvestment Ratio across 26 annual periods.
Annual Capital Reinvestment Ratio for Huadong Medicine Co Ltd (1998–2024)
Year-by-year Capital Reinvestment Ratio for Huadong Medicine Co Ltd from 1998 to 2024. For live market cap and broader valuation context, see market value of Huadong Medicine Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.46x | CN¥3.75 Billion | CN¥1.73 Billion | ▲ +12.7% |
| 2023 | 0.41x | CN¥3.93 Billion | CN¥1.61 Billion | ▼ -18.4% |
| 2022 | 0.50x | CN¥2.38 Billion | CN¥1.19 Billion | ▲ +93.9% |
| 2021 | 0.26x | CN¥3.17 Billion | CN¥819.10 Million | ▼ -40.2% |
| 2020 | 0.43x | CN¥3.41 Billion | CN¥1.47 Billion | ▼ -36.1% |
| 2019 | 0.68x | CN¥2.00 Billion | CN¥1.35 Billion | ▲ +57.3% |
| 2018 | 0.43x | CN¥2.04 Billion | CN¥876.46 Million | ▲ +49.1% |
| 2017 | 0.29x | CN¥1.66 Billion | CN¥478.69 Million | ▼ -16.9% |
| 2016 | 0.35x | CN¥1.35 Billion | CN¥467.00 Million | ▼ -40.4% |
| 2015 | 0.58x | CN¥658.54 Million | CN¥383.01 Million | ▲ +32.6% |
| 2014 | 0.44x | CN¥740.85 Million | CN¥324.89 Million | ▼ -37.7% |
| 2013 | 0.70x | CN¥476.98 Million | CN¥335.84 Million | ▲ +76.1% |
| 2012 | 0.40x | CN¥642.73 Million | CN¥256.97 Million | ▼ -97.1% |
| 2011 | 13.91x | CN¥16.12 Million | CN¥224.21 Million | ▲ +6009.9% |
| 2009 | 0.23x | CN¥567.94 Million | CN¥129.26 Million | ▼ -11.1% |
| 2008 | 0.26x | CN¥344.69 Million | CN¥88.24 Million | ▲ +110.8% |
| 2007 | 0.12x | CN¥265.79 Million | CN¥32.27 Million | ▼ -91.7% |
| 2006 | 1.46x | CN¥57.38 Million | CN¥83.53 Million | ▲ +492.0% |
| 2005 | 0.25x | CN¥203.33 Million | CN¥50.00 Million | ▼ -95.4% |
| 2004 | 5.33x | CN¥12.51 Million | CN¥66.60 Million | ▲ +558.2% |
| 2003 | 0.81x | CN¥90.54 Million | CN¥73.24 Million | ▼ -65.7% |
| 2002 | 2.36x | CN¥23.94 Million | CN¥56.47 Million | ▲ +386.1% |
| 2001 | 0.49x | CN¥109.67 Million | CN¥53.21 Million | ▼ -85.6% |
| 2000 | 3.37x | CN¥19.59 Million | CN¥66.01 Million | ▲ +1565.3% |
| 1999 | 0.20x | CN¥56.32 Million | CN¥11.40 Million | ▼ -62.1% |
| 1998 | 0.53x | CN¥23.80 Million | CN¥12.70 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow